Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Denton

Showing results (81-90 of 484) with videos related to

Pageof 49
Sort By:
Journal of Scleroderma and Related Disorders|April 6, 2022
Treatment of systemic sclerosis-associated interstitial lung disease: Lessons from clinical trialsDavid Roofeh, Oliver Distler, Yannick Allanore, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centreAmanda M Saracino, Christina George, Svetlana I Nihtyanova, et al.
International Journal of Molecular Sciences|April 28, 2023
Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in RatsGöran Tornling, Rohit Batta, Dan Salvail, et al.
BMJ Case Reports|March 12, 2018
The novel use of botulinum toxin A for the treatment of Raynaud's phenomenon in the toesKiran Dhaliwal, Michelle Griffin, Christopher P Denton, et al.
Experimental Physiology|September 10, 2025
Suppression of premature ventricular complexes with the PDE5 inhibitor sildenafil: First clinical experienceDavid C Hutchings, Christopher P Denton, Luigi Venetucci, et al.
Clinical and Experimental Rheumatology|February 28, 2020
Developing a quantitative tool to evaluate dermal fibrosis in systemic sclerosis patients: a case-control studyIraklis Giannakopoulos, Michelle Griffin, Christopher P Denton, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Development of systemic sclerosis in transgender females: a case series and review of the literatureCorrado Campochiaro, Lauren V Host, Voon H Ong, et al.
Clinical Rheumatology|April 15, 2020
Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysisChristopher P Denton, Bee Laird, Lizette Moros, et al.
Nature Reviews. Rheumatology|September 8, 2025
Emerging therapies for the treatment of systemic sclerosisJörg H W Distler, Masataka Kuwana, Shervin Assassi, et al.
Clinical Rheumatology|September 11, 2020
Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysisChristopher P Denton, Bee Laird, Lizette Moros, et al.
Pageof 49

Showing results (81-90 of 484) with videos related to

Sort By:
Pageof 49
Journal of Scleroderma and Related Disorders|April 6, 2022
Treatment of systemic sclerosis-associated interstitial lung disease: Lessons from clinical trialsDavid Roofeh, Oliver Distler, Yannick Allanore, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centreAmanda M Saracino, Christina George, Svetlana I Nihtyanova, et al.
International Journal of Molecular Sciences|April 28, 2023
Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in RatsGöran Tornling, Rohit Batta, Dan Salvail, et al.
BMJ Case Reports|March 12, 2018
The novel use of botulinum toxin A for the treatment of Raynaud's phenomenon in the toesKiran Dhaliwal, Michelle Griffin, Christopher P Denton, et al.
Experimental Physiology|September 10, 2025
Suppression of premature ventricular complexes with the PDE5 inhibitor sildenafil: First clinical experienceDavid C Hutchings, Christopher P Denton, Luigi Venetucci, et al.
Clinical and Experimental Rheumatology|February 28, 2020
Developing a quantitative tool to evaluate dermal fibrosis in systemic sclerosis patients: a case-control studyIraklis Giannakopoulos, Michelle Griffin, Christopher P Denton, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Development of systemic sclerosis in transgender females: a case series and review of the literatureCorrado Campochiaro, Lauren V Host, Voon H Ong, et al.
Clinical Rheumatology|April 15, 2020
Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysisChristopher P Denton, Bee Laird, Lizette Moros, et al.
Nature Reviews. Rheumatology|September 8, 2025
Emerging therapies for the treatment of systemic sclerosisJörg H W Distler, Masataka Kuwana, Shervin Assassi, et al.
Clinical Rheumatology|September 11, 2020
Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysisChristopher P Denton, Bee Laird, Lizette Moros, et al.
Pageof 49